Skip to main content
Enterprise AI Analysis: Explainable Artificial Intelligence for Predicting Cardiovascular Events in Hospitalized COVID-19 Patients

AI ANALYSIS REPORT

Explainable Artificial Intelligence for Predicting Cardiovascular Events in Hospitalized COVID-19 Patients

This study uses LightGBM and SHAP to predict cardiovascular events in hospitalized COVID-19 COVID-19 patients, identifying age, urea, platelet count, and oxygen saturation as key predictors. Despite high accuracy (94.6%), class imbalance led to low F1-scores for the minority class (5.2%), even after oversampling (max 21.5%). The models highlight AI's potential but also its limitations with rare events, emphasizing the need for advanced balancing techniques.

Executive Impact & Key Findings

Our AI models achieve high overall accuracy in predicting cardiovascular events, yet highlight critical challenges in detecting rare events due to class imbalance. This analysis offers insights into the nuanced application of AI in healthcare, emphasizing the need for targeted methodological advancements for reliable identification of low-prevalence, high-impact clinical outcomes.

0 Model Accuracy (Overall)
0 AUROC (Discrimination)
0 F1-Score (Minority Class, Oversampled)

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

Methodology
Performance Metrics
Key Predictors
Challenges

Robust AI Model Development Process

Our approach involved developing two LightGBM models. Model 1 incorporated 59 variables (demographic, clinical, laboratory, and socioeconomic data), while Model 2 used 52 variables, excluding socioeconomic factors. Performance was rigorously assessed using accuracy, macro-F1, recall, precision, and AUROC, with SHAP values providing interpretability by identifying key predictors.

Enterprise Process Flow

Retrospective Multicentre Cohort (10,700 patients)
Data Collection (25 hospitals, March/2021-August/2022)
Define Composite Outcome (Cardiovascular Events)
LightGBM Model Development (Model 1: 59 vars, Model 2: 52 vars)
Performance Assessment (Accuracy, F1, AUROC)
Class Imbalance Handling (Random Oversampling)
Predictor Identification (SHAP Values)
Explainable AI Insights

Balancing Accuracy with Minority Class Detection

The models achieved high overall accuracy (94.6% for Model 1, 94.5% for Model 2), but F1-scores for the minority class (cardiovascular events) were very low (5.2% and 4.2%). After oversampling, minority class recall improved substantially (22.2% and 23.1%), but precision dropped (20.7% and 21.8%), indicating a trade-off. This highlights the challenge of rare event prediction.

94.6% Overall Accuracy (Pre-Oversampling), highlighting high performance for the majority class.

Identified Risk Factors for Cardiovascular Events

SHAP analysis consistently identified age, urea, platelet count, and oxygen saturation/inspired oxygen fraction (SatO2/FiO2) as the most influential predictors across both models. Model 1 also highlighted socioeconomic indicators (Hospital GDP, Hometown GDP), while Model 2 emphasized arterial hypertension and pCO2 after excluding socioeconomic factors.

Predictor Category Model 1 (with Socioeconomic) Model 2 (without Socioeconomic)
Top Clinical Predictors
  • Age
  • Urea
  • Platelet Count
  • SatO2/FiO2
  • Heart Failure
  • Respiratory Rate
  • Arterial pCO2
  • Age
  • Urea
  • Platelet Count
  • SatO2/FiO2
  • Arterial Hypertension
  • Arterial pCO2
  • Respiratory Rate
  • Heart Failure
Socioeconomic Impact
  • Hospital GDP
  • Hometown GDP
No direct socioeconomic variables

Addressing Class Imbalance in Rare Event Prediction

A significant challenge was the strong class imbalance, with only 5.3% of patients experiencing cardiovascular events. Traditional rebalancing techniques like random oversampling improved recall but reduced precision, leading to a trade-off with more false positives. This underscores the need for more advanced, context-specific balancing strategies in AI for healthcare.

The Imbalance Dilemma

Client: Hospitalized COVID-19 Patients Cohort (10,700 patients)

Challenge: Predicting rare cardiovascular events (5.3% incidence) in COVID-19 patients with high reliability.

Solution: Developed LightGBM models with SHAP for interpretability. Applied random oversampling to mitigate class imbalance.

Results: Oversampling boosted minority class recall (from ~2.5% to ~22%) but drastically reduced precision (from ~35% to ~21%), highlighting a critical trade-off. Overall F1-score for minority class remained low (max 21.5%), indicating persistent difficulty in precise identification of rare events despite improved sensitivity.

Calculate Your Potential ROI with AI

Estimate the potential impact of predictive AI on your healthcare operations.

Estimated Annual Savings $0
Hours Reclaimed Annually 0

Your AI Implementation Roadmap

Our phased approach ensures a smooth integration of AI solutions tailored to your enterprise.

Discovery & Strategy

Understand your specific challenges, data landscape, and define clear AI objectives.

Data Engineering & Model Training

Prepare and preprocess data, then train and validate initial AI models.

Pilot Deployment & Iteration

Deploy a pilot system, gather feedback, and refine the model for optimal performance.

Full-Scale Integration & Monitoring

Integrate the AI solution across your enterprise, with continuous monitoring and maintenance.

Performance Optimization & Scaling

Regularly optimize model performance and scale the solution to new areas of your business.

Ready for an AI Transformation?

Ready to transform your healthcare risk prediction with explainable AI? Schedule a personalized strategy session to discuss how our solutions can integrate with your existing systems and deliver tangible benefits.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking